The Gothenburg breast screening trial: First results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization

Cancer

Volumn 80, Issue 11, 1997, Pages 2091-2099

  Bjurstam, Nils ^a   Björneld, Lena ^a   Duffy, Stephen W ^b   Smith, Teresa C ^b   Cahlin, Erling ^a   Eriksson, Olof ^a   Hafström, Lars Olof ^c   Lingaas, Halvard ^a   Mattsson, Jan ^a   Persson, Stellan ^a   Rudenstam, Carl Magnus ^a   Säve Söderbergh, Johan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Age specific effects; Breast carcinoma; Mammographic screening; Randomized trial

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SWEDEN;

EID: 1842335164     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19971201)80:11<2091::aid-cncr8>3.0.co;2-%23     Document Type: Article

References (21)

1. Shapiro S, Venet W, Strax P, Venet L. Periodic screening for breast cancer: the Health Insurance Plan Project and its Sequelae 1963-86. Baltimore: Johns Hopkins University Press, 1988.
2. Alexander FE, Anderson TJ, Brown HK, Forrest APM, Hepburn W, Kirkpatrick AE, et al. The Edinburgh randomized trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 1994;70:542-8.
3. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age: new results from the Swedish two-county trial. Cancer 1995; 75:2507-17.
4. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988;297:943-8.
5. Frisell J, Eklund G, Hellström L, Lindbrink E, Rutqvist LE, Somell A. Randomized study of mammographic screening: preliminary report on mortality in the Stockholm Trial. Breast Cancer Res Treat 1991;18:49-56.
6. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992; 147:1459-76.
7. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 1992; 147:1477-88.
8. Hendrick RE, Smith RA, Rutledge JH, Smart CR. Benefit of screening mammography in women ages 40-49: a new meta-analysis of randomized controlled trials. Monogr Natl Cancer Inst 1997;22:87-92.
9. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, et al. Breast cancer screening with mammography: overview of Swedish randomized controlled trials. Lancet 1993;341:973-8.
10. Glasziou PP, Woodward AJ, Mahon CM. Mammographic screening trials for women aged under 50: a quality assessment and meta-analysis. Med J Aust 1995;162:625-9.
11. Organising Committee and Collaborators, Falun meeting. Breast cancer screening with mammography in women aged 40-49 years. Int J Cancer 1996;68:693-9.
12. Tabar L, Fagerberg G, Day NE, Holmberg L. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 1987;55:547-51.
13. Nyström L, Larsson LG, Rutqvist LE, Lindgren A, Lindqvist M, Ryden S, et al. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials: a comparison between official statistics and validation by an endpoint committee. Acta Oncol 1995; 34:145-52.
14. Breslow NE, Day NE. Statistical methods in cancer research II. The design and analysis of cohort studies. Lyon: International Agency for Research on Cancer, 1987.
15. Paci E, Duffy SW. Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986). Int J Epidemiol 1991;20:852-8.
16. Bjurstam N, Björneld L, Duffy SW, Smith TC, Cahlin E, Eriksson O, et al. The Gothenburg Breast Screening Trial: preliminary results on breast cancer mortality for women aged 39-49. Monogr Natl Cancer Inst 1997;22:53-55.
17. Duffy SW, Chen HH, Tabar L, Fagerberg G, Paci E. Sojourn time, sensitivity and positive predictive value of mammography screening in women aged 40-49. Int J Epidemiol 1996; 25:1139-45.
18. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay I, Powell J. Cancer incidence in five continents. Volume VI. Lyon: International Agency for Research on Cancer, 1992.
19. National Board of Health and Welfare, The Cancer Registry. Cancer incidence in Sweden 1975 and 1976. Stockholm: Schmidts Boktryckeri, 1980.
20. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish Two-County Program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210.
21. Cuzick J, Edwards R, Segnan N. Adjusting for non-compliance and contamination in rand omized clinical trials. Stat Med 1997;16:1017-29.